SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008425
Filing Date
2022-05-12
Accepted
2022-05-12 07:21:20
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q thrx-20220331x10q.htm   iXBRL 10-Q 1133856
2 EX-31.1 thrx-20220331xex31d1.htm EX-31.1 15016
3 EX-31.2 thrx-20220331xex31d2.htm EX-31.2 15231
4 EX-32.1 thrx-20220331xex32d1.htm EX-32.1 8024
5 EX-32.2 thrx-20220331xex32d2.htm EX-32.2 8017
  Complete submission text file 0001558370-22-008425.txt   4936756

Data Files

Seq Description Document Type Size
6 EX-101.SCH thrx-20220331.xsd EX-101.SCH 33159
7 EX-101.CAL thrx-20220331_cal.xml EX-101.CAL 35236
8 EX-101.DEF thrx-20220331_def.xml EX-101.DEF 150105
9 EX-101.LAB thrx-20220331_lab.xml EX-101.LAB 336895
10 EX-101.PRE thrx-20220331_pre.xml EX-101.PRE 281831
59 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20220331x10q_htm.xml XML 722144
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 22915706
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences